These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Decrement of compound muscle action potential is related to mutation type in myotonia congenita. Colding-Jørgensen E; DunØ M; Schwartz M; Vissing J Muscle Nerve; 2003 Apr; 27(4):449-55. PubMed ID: 12661046 [TBL] [Abstract][Full Text] [Related]
24. Abnormalities of the fast sodium current in myotonic dystrophy, recessive generalized myotonia, and adynamia episodica. Rüdel R; Ruppersberg JP; Spittelmeister W Muscle Nerve; 1989 Apr; 12(4):281-7. PubMed ID: 2549413 [TBL] [Abstract][Full Text] [Related]
25. Enhanced slow inactivation by V445M: a sodium channel mutation associated with myotonia. Takahashi MP; Cannon SC Biophys J; 1999 Feb; 76(2):861-8. PubMed ID: 9929487 [TBL] [Abstract][Full Text] [Related]
28. Mutant channels contribute <50% to Na+ current in paramyotonia congenita muscle. Mitrovic N; George AL; Rüdel R; Lehmann-Horn F; Lerche H Brain; 1999 Jun; 122 ( Pt 6)():1085-92. PubMed ID: 10356061 [TBL] [Abstract][Full Text] [Related]
29. A CLCN1 mutation in dominant myotonia congenita impairs the increment of chloride conductance during repetitive depolarization. Tsujino A; Kaibara M; Hayashi H; Eguchi H; Nakayama S; Sato K; Fukuda T; Tateishi Y; Shirabe S; Taniyama K; Kawakami A Neurosci Lett; 2011 Apr; 494(2):155-60. PubMed ID: 21385601 [TBL] [Abstract][Full Text] [Related]
30. Class Ic antiarrhythmics block human skeletal muscle Na channel during myotonia-like stimulation. Aoike F; Takahashi MP; Sakoda S Eur J Pharmacol; 2006 Feb; 532(1-2):24-31. PubMed ID: 16473348 [TBL] [Abstract][Full Text] [Related]
31. Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita. Ginanneschi F; Mignarri A; Lucchiari S; Ulzi G; Comi GP; Rossi A; Dotti MT Neurophysiol Clin; 2017 Jun; 47(3):247-252. PubMed ID: 28153715 [TBL] [Abstract][Full Text] [Related]
32. Inactivation of muscle chloride channel by transposon insertion in myotonic mice. Steinmeyer K; Klocke R; Ortland C; Gronemeier M; Jockusch H; Gründer S; Jentsch TJ Nature; 1991 Nov; 354(6351):304-8. PubMed ID: 1659665 [TBL] [Abstract][Full Text] [Related]
33. Activity-induced weakness in recessive myotonia congenita with a novel (696+1G>A) mutation. McKay OM; Krishnan AV; Davis M; Kiernan MC Clin Neurophysiol; 2006 Sep; 117(9):2064-8. PubMed ID: 16854622 [TBL] [Abstract][Full Text] [Related]
34. In vitro muscle contracture investigations on the malignant hyperthermia like episodes in myotonia congenita. Hoppe K; Lehmann-Horn F; Chaiklieng S; Jurkat-Rott K; Adolph O; Klingler W Acta Anaesthesiol Scand; 2013 Sep; 57(8):1017-23. PubMed ID: 23639175 [TBL] [Abstract][Full Text] [Related]
35. Membrane defects in paramyotonia congenita with and without myotonia in a warm environment. Lehmann-Horn F; Rüdel R; Dengler R; Lorković H; Haass A; Ricker K Muscle Nerve; 1981; 4(5):396-406. PubMed ID: 6270549 [TBL] [Abstract][Full Text] [Related]
36. Low-rate repetitive nerve stimulation protocol in an Italian cohort of patients affected by recessive myotonia congenita. Modoni A; D'Amico A; Dallapiccola B; Mereu ML; Merlini L; Pagliarani S; Pisaneschi E; Silvestri G; Torrente I; Valente EM; Lo Monaco M J Clin Neurophysiol; 2011 Feb; 28(1):39-44. PubMed ID: 21221019 [TBL] [Abstract][Full Text] [Related]
37. Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia. Desaphy JF; Camerino DC; Tortorella V; De Luca A Neuromuscul Disord; 1999 May; 9(3):182-9. PubMed ID: 10382914 [TBL] [Abstract][Full Text] [Related]